Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

VISIOWELL : a high-throughput imaging device for non-adherent cells

Project description

Ex vivo live-cell imaging tool for non-adherent cells

Studying single-cell dynamics is vital for understanding development, immune responses, and cancer treatment. Ex vivo live-cell imaging improves analysis, but lacks commercial options for non-adherent cells like immune and cancer cells. This limitation hinders drug screening and therapy development. The ERC-funded VisioWell project will create an accessible solution for ex vivo single-cell live-cell imaging focused on motile cells. Designed for non-specialists, this end-to-end tool will use simple lab equipment, such as standard imaging platforms or microscopes. The project will conduct testbeds in drug screening and clinical sample analysis. It will partner with academic and industrial stakeholders to distribute the device, enabling non-specialists to access this innovative imaging method and advance research and development for translational applications.

Objective

Measuring single cell dynamics (cell division and death) is crucial to understand organism development, tissue regeneration, immune response, cancer development, response to treatment. For example, it can identify if a treatment induces cell death or a block in division on a given cells during drug screening. Ex-vivo single cell live-cell imaging can unlock the single cell dynamics analysis for translational research. Unfortunately, no options are commercially available for the study of non-adherent cells (immune cells, blood cells and progenitors, sperm cells, oocytes or circulating cancer cells). This hampers drug screening and bioengineering, affecting the development of novel therapies. The main requirements are high throughput to analyse thousands of single cell in parallel and efficient automated image data analysis. Moreover, this type of analysis requires specialists in biology, image analysis and data science. With VisioWell, we will develop the first accessible solution for ex-vivo single cell live-cell imaging on motile cells. VisioWell is an end-to-end tool, conceived specifically for motile cells and developed for non-specialists in microfabrication and imaging analysis. It leverages microfabrication and machine learning, allowing complex experimental designs with simple lab equipment (e.g. imaging
platform or a microscope for live-cell protocols). To establish the potential of VisioWell, we will perform two testbeds, covering drug screening and clinical sample analysis. We will distribute this device through partnerships with academic and industrial stakeholders.VisioWell can unlock the potential of ex vivo single cell live-cell imaging for non-specialists. Access to this method will advance research and development for translational purposes.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOGIPUZKOA
Net EU contribution
€ 150 000,00
Address
PASEO DR BEGUIRISTAIN SN
20014 DONOSTIA-SAN SEBASTIAN
Spain
Region
Noreste País Vasco Gipuzkoa
Activity type
Research Organisations
Links
Total cost
No data

Beneficiaries (2)